Transcervical Thymectomy



Transcervical Thymectomy


Larry R. Kaiser



INTRODUCTION

With so much emphasis today being placed on new minimally invasive techniques, it is easy to forget that some minimally invasive procedures have been around for years but seemingly never referred to as such. In a sense, one can make a strong case that transhiatal esophagectomy is a minimally invasive operation since it avoids a chest incision and we have been doing that procedure for many years, thanks to Mark Orringer popularizing it back in the 1970s. Other procedures have been “minimized” with smaller incisions, muscle sparing, and, of course, with the use of endoscopes.

Removal of the nontumorous thymus gland for myasthenia gravis classically involved a median sternotomy and despite the efforts of some to utilize a so-called mini sternotomy, at least a portion of the sternum is still split. Jaretski in New York described even a more “maximal” approach utilizing a neck incision combined with a sternotomy making the case that aberrant “rests” of thymus occurred in locations that even a standard sternotomy might miss (Fig. 14.1). It occurred at least to a few surgeons that performing a sternotomy to remove a normal thymus gland was overkill. Working in the same city, Papatestas resurrected the transcervical approach to thymectomy during the 1970s and 1980s with results, relative to myasthenic symptoms, similar to those obtained via the much larger and more morbid operation. Cooper made a major modification to the transcervical approach by designing a retractor that instead of strictly relying on blind blunt dissection, as practiced by Papatestas, allowed for direct visualization of the anterior mediastinum to assure that all of the thymus gland was removed. Both pleural reflections could be visualized; the inferior extent of the gland and the extension of the gland into the aortopulmonary window could also be directly visualized. The Cooper thymectomy retractor allowed for an extended transcervical thymectomy, an approach more predictable and reliable.

Recognizing that a median sternotomy is a big operation with significant attendant morbidity simply to remove a normal structure that easily dissects away from surrounding structures with blunt dissection further made the case for transcervical thymectomy. However, there remained a significant group of vocal opponents to the procedure based on their contention that a transcervical approach failed to remove the entire thymus gland and certainly would miss rest of the gland that, according to Jaretski, commonly occurred in aberrant locations. The objection fundamentally was based on the contention that complete removal of the entire thymus gland was absolutely necessary if one was to achieve a complete remission of myasthenic symptoms. Whether or not that contention is valid still remains an open question. This has been further called into question since in at least one study it has been shown that in patients with ectopic thymic rests, even when removed, the incidence of complete remission remains significantly inferior to that seen in those who do not have ectopic gland. Thus, in a setting in which no procedure results in 100% remission rates, we need to look critically at the type of operation and specifically at the risk-benefit ratio involved in removing what is essentially a normal structure. It has been our hypothesis that transcervical thymectomy should be the preferred approach for the removal of the thymus gland in patients with myasthenia gravis. We believe that the risk-benefit ratio is favorable enough to make the case that essentially all patients with myasthenia should be offered thymectomy via this approach. Even those neurologists who are concerned about subjecting their patients to a surgical procedure often are swayed when they are informed about the minimally invasive nature of this procedure and the results when compared with the open procedure.